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Background: Parkinson's disease (PD) is often associated with depression and anxiety. The availability of
evidence-based psychological interventions is low.
Objective: This pilot study investigates the feasibility and preliminary effect of internet-based cognitive behavior-
al therapy (ICBT) for depression and anxiety in PD.
Methods: 9 patients with PD with comorbid symptoms on the relevant subscale of Hospital Anxiety and Depres-
sion Scale (HADS), of either depression (HADS-D N 7) or anxiety (HADS-A N 7) received 12 weeks of ICBT, spe-
cially adapted for depression and anxiety in PD. Primary outcome was change in depression and anxiety
symptoms, measured with HADS total score. Effects on non-motor symptoms, PD speciﬁc health and quality of
life and insomnia were explored, plus the participant's involvement, satisfaction, and subjective evaluation of
the treatment.
Results: Participants reported lower symptoms on HADS after ICBT (Cohen's d=0.79, p b 0.05). However, levels
of inactivity were rather high and questionnaires and comments from participants suggested that the treatment
can be improved, for example by adding more therapist support.
Conclusions: The results suggest that ICBT could be a feasibleway to alleviate depression and anxiety in PD. How-
ever, a somewhat simpliﬁed treatment and differentways to provide support to enhance adherence and outcome
are warranted.© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Parkinson's disease (PD) is the secondmost commonneurodegener-
ative disease, often associated with motor symptoms such as rigidity
and resting tremor. PD is also often associated with comorbid depres-
sion, anxiety and sleep problems which impair the quality of life. A re-
cent systematic review is suggesting that the prevalence of clinically
relevant depression in patients with PD is 30–35% (Aarsland et al.,
2012). Even more patients have symptoms of depression and anxiety
but do not meet all criteria for a diagnosis (Aarsland et al., 2012).
Most patients with PD also have some form of sleep disorder (Larsen
and Tandberg, 2001).
There are only a few studies examining psychological interventions
for depression and anxiety in Parkinson's disease (Yang et al., 2012).
These studies suggest that cognitive behavioral therapy (CBT) can be ef-
fective. One randomized trial (n= 80) has beenmadewhere the group
receiving CBT experienced a clearly signiﬁcant reduction in depressiveClinic, Karolinska University
38 59.
n).
. This is an open access article undersymptoms compared with the group receiving the usual clinical moni-
toring (Cohen's d= 1.59) (Dobkin et al., 2011a).
The availability of CBT is unfortunately low,mostly because of lack of
CBT-trained therapists (Larsson et al., 2009). New ways to administer
CBT as self-help via books, telephone and internet, can increase access
to treatment and reduce costs. Self-help with therapist support has
proven to be as effective as traditional CBT in a range of conditions
(Cuijpers et al., 2010).
Besides the lack of CBT trained therapists, PD patients may have dif-
ﬁculty getting to weekly sessions at the clinic. In a survey, 31% of PD pa-
tients reported transportation as a barrier to mental health care
utilization and 52% said that mental health services were not available
locally (Dobkin et al., 2013). The same survey reported that a majority
had access to phone, cell phone and internet, and felt comfortable
using both phone and computer.
A small case study (n = 10) evaluated telephone-administered CBT
for PD patients with comorbid depressive or anxiety disorders with
promising results (Veazey et al., 2009). These study participants report-
ed that they preferred to manage their CBT treatment from home com-
pared to having to travel to the clinic once aweek. Another uncontrolled,
but larger study (n = 21) of telephone CBT for depression in PD found
promising improvements in depression score (Cohen's d = 1.21)the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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phone CBT mirrored standard face-to-face CBT in both content and ses-
sion length and where not based on guided self-help where the main
content of the treatment is delivered via text or other media and the
therapist is mainly giving additional support and feedback.
Internet-based CBT (ICBT) usually consists of self-help texts, home-
work assignments, queries and guidance by an online therapist
(Andersson et al., 2008). The evidence of guided ICBT's effectiveness
and cost-beneﬁt is rapidly growing (Hedman et al., 2012). ICBT has pre-
viously been used to treat both psychiatric conditions such as panic dis-
order (Hedman et al., 2013) and distress related to somatic problems
such as tinnitus (Kaldo et al., 2008). Internet-based interventions have
also been used successfully with other neurology patients in two small-
er studies, one treating depression in epilepsy (n = 40) (Thompson
et al., 2010) and one managing fatigue in multiple sclerosis (n = 40)
(Moss-Morris et al., 2012). To our knowledge, studies of ICBT for depres-
sion and anxiety in Parkinson's disease are lacking.
1.1. Aim of this study
The aim of this study was to investigate the feasibility and prelimi-
nary effect of ICBT for depression and anxiety in Parkinson's disease.
We hypothesized that participants would improve on measures of
symptoms of depression and anxiety. We also explored effects on PD
non-motor symptoms, PD speciﬁc health and quality of life, and insom-
nia as well as involvement in treatment, the participant's satisfaction
and subjective evaluation of the treatment.
2. Methods
2.1. Design
This was an uncontrolled study to evaluate the effect ICBT had on
depression and anxiety symptoms in PD patients (n = 9). A within-
group design with repeated measurements was used. The study was
approved by the Regional Ethics Review Board in Stockholm, Sweden
(2011/1844-31/4). The studywas also registered at ClinicalTrials.gov
(NCT01545414).Table 1
Baseline characteristics of participants.
Characteristic n = 9
Age, years, m (sd) 66.0 (11.6)
Age span, youngest–oldest, years 37–74
Gender, n (%)
Women 3 (33%)
Men 6 (67%)
Marital status, n (%)
Married/living with partner 8 (89%)
Separated/divorced/widowed 1 (11%)
Single/other
Educational level, n (%)
Compulsary school/other 0
Upper secondary school 4 (44%)
College/university 5 (56%)
Current occupation, n (%)
Work/studies full time 0
Work/studies part time 2 (22%)
Retired/sick leave/unemployed/other 7 (78%)
Quality of life in PD (PDQ-39SI), m (sd) 35.5 (12.8)
PD severity (UPDRS), m (sd) 41.2 (16.0)
Cognitive functioning (MoCA), n = 8, m (sd) 26.4 (1.6)
Years since PD diagnosis, m (sd) 8.1 (3.9)
Uses antidepressants, n (%) 2 (22%)
Levodopa equivalent doses medication, m (sd)a 835 (322) mg
Abbrevations: PD, Parkinson's disease; PDQ-39SI, The ParkinsonDisease Questionnaire-39
Single Index; UPDRS, Uniﬁed Parkinson's Disease Rating Scale; MoCA, Montreal Cognitive
Assessment.
a See Tomlinson et al. (2010).2.2. Sample and recruitment
Table 1 presents the characteristics of the participants included in
this study. Participants were recruited by a neurologist (PS) at the PD
unit at the Neurology Department at the Karolinska University Hospital,
Stockholm, Sweden between December 2011 andMarch 2013. After PD
assessmentwith Uniﬁed Parkinson's Disease Rating Scale, UPDRS (Fahn
et al., 1987), the participant completed questionnaires through a secure
web page.
Inclusion criteria were: (a) a previously diagnosed PD and (b) mild
to moderate depression or anxiety problems deﬁned as Hospital Anxi-
ety and Depression Scale (Zigmond and Snaith, 1983) subscale for anx-
iety (HADS-A), or subscale for depression (HADS-D), greater than 7
(Bjelland et al., 2002). Exclusion criteria were: (c) current drug abuse,
(d) psychosis or bipolar disorder, (e) problems that prevent the use of
computer or internet, (f) lack of time or ability to perform the exercises
in ICBT, (g) cognitive function less than 24 on Montreal Cognitive As-
sessment (MoCA) (Gill et al., 2008), (h) severe depression deﬁned as
over 30 on Montgomery Åsberg Depression Rating Scale — Self rating
version, MADRS-S (Mattila-Evenden et al., 1996), high suicide risk de-
ﬁned as (i) 5 or 6 points on the MADRS-S question on suicidal thoughts
or (j) a high suicide risk identiﬁed by the neurologist or the psychologist
interviewing the participant. Participants were not excluded on the
basis of any concurrent medical, physiological or psychological
treatment.
In the next step, the participant was interviewed face-to-face by a
psychologist (MK)which served as the start of the internet-based treat-
ment phase. Once every treatment week, the participants completed
the MADRS-S over the internet. If the MADRS-S question on suicidality
was above 3, the psychologist contacted the participant to perform a
structured evaluation for suicidal ideation. In treatment week 12 the
participant again completed internet questionnaires and was then
interviewed again face-to-face by the psychologist. All treatment was
an adjunct to standard medical treatment in PD. After treatment the
participant was assessed again by a neurologist at the PD unit.
2.3. Outcome measures
2.3.1. Primary outcome
The primary outcome measure was anxiety and depression symp-
toms measured with the HADS scale (Zigmond and Snaith, 1983). The
HADS measures the degree of anxiety and depression both as indepen-
dent subscaleswith 7 items each, HADS-A andHADS-D, and as a 14 item
total score. The score range is 0–21 for each subscale and 0–42 for the
total score. HADS has shown internal consistency with a Cronbach's α
of 0.83 for HADS-A and 0.82 for HADS-D (Bjelland et al., 2002). Internet
administration of the HADS has also shown to be valid (Andersson et al.,
2003).
2.3.2. Secondary outcomes
A secondary outcome measure was degree of depression measured
with MADRS-S which is a psychometrically sound measure and highly
correlated to other measures of depression (Mattila-Evenden et al.,
1996). The score range for MADRS-S is 0–54. Degree of insomnia was
measured with Insomnia Severity Index, ISI which has shown adequate
psychometric properties (Bastien et al., 2001). The score range for ISI is
0–28. The ParkinsonDiseaseQuestionnaire, PDQ-39was used at screen-
ing to assess PD speciﬁc health and quality of life in 8 dimensions
(Jenkinson et al., 1997a). The PDQ-8 is a shorter form measure of the
same dimensions as in PDQ-39 and highly correlated to the 39 item ver-
sion (Jenkinson et al., 1997b). The PDQ-8 was used at pre- and post-
treatment to measure change in PD related health and quality of life
by calculating the PDQ-8 Single Index, PDQ-8SI. Level of non-motor
symptoms was measured with the Non-motor Symptoms Question-
naire, NMSQuest (Chaudhuri et al., 2006).
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2.4.1. Participant involvement in treatment
Participant involvement in treatment was measured with the num-
ber of messages each participant sent to the therapist, the number of
treatment modules accessed per participant and the number of home-
work assignment reports completed per participant. These measures
were automatically registered in the treatment platform.
2.4.2. Therapist activity
Therapist activity per participant was measured with the number of
messages sent to each participant, the total time spent on writing mes-
sages to each participant, the number of phone calls per participant and
the total time spent on phone calls per participant.
2.4.3. Satisfaction and subjective evaluation
Satisfactionwith treatment was assessed at post-treatment with the
eight item Client Satisfaction Questionnaire, CSQ-8 (Attkisson and
Zwick, 1982). This questionnaire includes both numerically rated prop-
ositions and the possibility to provide written comments to each prop-
osition (see Table 4). Thesewritten comments constituted an important
basis for the qualitative evaluation of the treatment program. This
established questionnaire was complementedwith self-rated questions
about the amount of interaction with the treatment and a semi-
structured interview about the experience of ICBT done by the
psychologist.
2.5. Treatment
The initial psychologist interview provided the psychologist with
clinical information relevant to the ICBT intervention including choice
of optional treatment modules and a ﬁrst deﬁnition of the participant's
treatment goals. The ICBT program was then accessible to the partici-
pant later the same day. Table 2 presents the content of the 12 week
ICBT protocol. It consisted of mandatory and optional treatment mod-
ules which were accessed by the participant one at a time. A module
consisted of educative texts, interactive forms and practical exercises.
The maximum possible number of different modules for a partici-
pant was 11. Each module was designed to be used a ﬂexible number
ofweeks to perform the amount of practical exercise needed to facilitate
change. Modules were altered compared to the modules used in the
regular ICBT-program for depression used at the Internet Psychiatry
Clinic, Stockholm Sweden (Hedman et al., 2014). To meet the needs
of the PD patient group, who may suffer from lowered executive func-
tioning (Lees et al., 2009), the paragraphs and total amount of text
were shorter, there were more pictures and illustrations, and all exam-
ples were PD speciﬁc. A typical module contained around 3000 words
compared to 6000–9000 words per module used in the regular depres-
sion treatment for non-PD patients. The mandatory modules were
based on behavioral activation to alleviate depressive symptoms and
management of avoidance behaviors. The optional modules targetedTable 2
Content of the treatment modules.
Treatment module Mandatory/optionala
1. Introduction Mandatory
2. Behavioral activation Mandatory
3. Avoidance and mastery Mandatory
Sleep and circadian rhythm Optional
Social anxiety Optional
Cognitive distortions Optional
Mindfulness Optional
Physical exercise Optional
Relaxation Optional
Last module Mandatory
a An optional module for panic disorder was not used in this study, since none of the particispeciﬁc problemswith the appropriate traditional CBTmethods. During
treatment, the therapist contacted the participant via the treatment
platform after each ﬁnished module and by phone in case of inactiv-
ity, technical problems, or indications of suicidality. The therapist
(MK) had training and experience in CBT and ICBT for depression
and anxiety with adults but no earlier experience of working with
PD patients. The therapist was supervised by the neurologist (PS)
in PD speciﬁc questions.
2.6. Data analysis
Descriptive statistics were calculated to summarize demographics
and characteristics at baseline. Outcome measures were evaluated
from baseline to end of ICBT with T-tests and Cohen's dwas then calcu-
lated as a measure of within group effect size. In case of missing data at
post treatment, the last available observation was used as post data in
accordance with an intent-to-treat analysis with last observation car-
ried forward. All participants were included in the description of partic-
ipant adherence and activity and therapist activity while only
participants who completed the client satisfaction questionnaires
were used in the client satisfaction analysis.
3. Results
3.1. Recruitment and attrition
Thirteen participants were screened for inclusion in the pilot study.
The participants' ﬂow throughout the study can be seen in Fig. 1.
Three participants dropped out from treatment. Interviews gave that
in two cases this was because of problems in managing the technologi-
cal aspects of the treatment, and in one case the reason was difﬁculties
in concentrating on the treatment. Two post treatment questionnaires
were lost and one post treatment questionnaire did not include the pa-
tient satisfaction forms.
3.2. Primary outcome — depression and anxiety
Change in anxiety and depression symptoms, measured with the
total score of the HADS scale, can be seen in Table 3. The change in
HADS mean score was moderate and was statistically signiﬁcant
(t(8) = 3.09; p b .05). The change in depression symptoms (HADS-D)
was also signiﬁcant (t(8) = 2.44; p b .05). The change in anxiety symp-
toms (HADS-A) encompassed a small and non-signiﬁcant change.
3.3. Secondary outcomes
No signiﬁcant effects were observed in degree of depression mea-
sured with MADRS-S, insomnia measured with ISI, PD related health
and quality of life measured with PDQ-8SI or non-motor symptoms
measured with NMSQuest (Table 3).Homework assignment
Identifying values and setting long term goals
Activity scheduling
Activity scheduling
Sleep diary and sleep restriction
Anxiety hierarchy and graded exposure
Cognitive reappraisal
Mindfulness and acceptance exercises
Scheduling of physical exercise
Progressive relaxation training with audio ﬁles
Summary and future
pants received it in their personalization of treatment.
Fig. 1. Participants' ﬂow through the study.
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The participants sent on average 8.3 (SD = 7.5) messages, ranging
from 0 to 24 messages per participant. Each participant accessed on av-
erage 3.4 (SD= 2.1) treatment modules, ranging from 1 to 7 treatment
modules per participant. The most used optional treatment modules
where relaxation, social anxiety and sleep and circadian rhythm. Each
participant submitted on average 3.0 (SD=3.9) homework assignment
report forms, ranging from 0 to 11 reports per participant.3.5. Therapist activity
The therapist sent on average 8.8 (SD = 7.4) messages to each par-
ticipant, ranging from 1 to 24 messages per participant. The total time
spent on writing messages to each participant was on average 118.2
(SD = 98.3) minutes ranging from 4.6 to 275.2 min per participant,
this equals an average of 10min per participant andweek. The therapist
called the participant on average 2.8 (SD=3.3) times, ranging from0 to
8 phone calls per participant. The total time spent on phone calls with
each participant was on average 31.8 (SD = 41.5) minutes, ranging
from 0 to 111 min, this equals less than 3 min per participant and
week on average.Table 3
Observed mean (SD), change values and effect sizes (n = 9).
Pre Postb C
Mean (SD) Mean (SD) M
Main outcome: anxiety and depression
HADS 20.1 (6.2) 15.3 (6.0) −
HADS-A, anxiety 9.6 (5.7) 7.6 (4.1) −
HADS-D, depression 10.6 (2.7) 7.8 (2.5) −
Secondary outcomes
MADRS-S, depression 16.7 (6.0) 14.2 (8.5) −
ISI, insomnia 11.8 (5.4) 10.9 (5.3) −
PDQ-8SI, PD related health 37.2 (14.6) 37.2 (20.0)
NMSQuest, non-motor symptoms 12.6 (5.9) 12.1 (5.8) −
Abbreviations: Pre, Pre-treatment assessment; Post, Post-treatment assessment; HADS, Hospita
Self rating; ISI, Insomnia Severity Index; PDQ-8SI, The Parkinson Disease Questionnaire-8 Sing
a Effect sizes calculated within groups, pre-post, with pooled standard deviation.
b Last observation carried forward, in case of missing data at post.3.6. Satisfaction and involvement
3.6.1. Quantitative analysis
The participants who completed the CSQ-8 (n = 6) scored an aver-
age of 19.67 (SD= 4.03) out of a possible 32 indicating a moderate de-
gree of patient satisfaction. Degree of satisfaction measured with CSQ-8
did not correlate with change in depression and anxiety symptoms
measured with HADS.
The participants who completed the CSQ-8 (n = 6) also rated their
degree of involvement in treatment on a number of questionswhich in-
cluded the questions seen in Table 4. These self-ratings reveal that al-
though many participants considered the amount of text to be too
much, they often found it interesting and relevant and, on average,
they readmost of it. Many participants admitted to notworking very ac-
tively with the homework assignments, and another potential problem
was that many participants did not contact the therapist every time
they encountered a problem, or had a question.3.6.2. Comments and interview
The participants' written comments about treatment satisfaction
and semi-structured interviews showed high satisfaction with the
telephone-based parts of treatment, example quote: “The contact overhange pre to post
ean difference (95% CI) Effect size d (95% CI)a T-test
4.8 (−8.3 to−1.2) 0.79 (1.36 to 0.20) t(8) = 3.09; p b .05
2.0 (−4.6 to +0.6) 0.40 (0.94 to−0.12) t(8) = 1.75; p = .118
2.8 (−5.4 to−0.1) 1.08 (2.08 to 0.04) t(8) = 2.44; p b .05
2.4 (−7.9 to +3.1) 0.34 (1.09 to−0.43) t(8) = 1.02; p = .336
0.9 (−3.8 to +2.0) 0.17 (0.71 to−0.37) t(8) = 0.71; p = .498
0.0 (−6.5 to +6.5) 0.00 (0.38 to−0.38) t(8) = 0.00; p = 1.00
0.4 (−2.0 to +1.1) 0.08 (0.34 to−0.19) t(8) = 0.66; p = .525
l Anxiety and Depression Scale; MADRS-S, Montgomery Åsberg Depression Rating Scale—
le Index; PD, Parkinson's disease; NMSQuest, Non-motor Symptoms Questionnaire.
Table 4
Participant involvement in treatment (n = 6).
n (%)
How often was the text interesting and relevant?
Never 0
Seldom 0
Sometimes 3 (50%)
Often 1 (17%)
Always 2 (33%)
Was the amount of text too much or too little?
Way too little 0
Too little 1 (17%)
Just right 2 (33%)
Too much 3 (50%)
Way too much 0
How much of all text did you read in total?
None 0
25% 1 (17%)
50% 0
75% 1 (17%)
100% 4 (67%)
How actively did you work with the homework assignments?
I did not do any homework assignments at all 0
I did not work very actively with the homework assignments 3 (50%)
I worked quite actively with the homework assignments 2 (33%)
I worked actively with most homework assignments 1 (17%)
I did all the homework assignments 0
When you had a problem or questions, how often did you
contact the therapist?
Never 1 (17%)
Occasionally 2 (33%)
Every other time 1 (17%)
Almost every time 2 (33%)
Every time 0
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ples of speciﬁc gains in function, example quote: “I cannot determine
what has inﬂuencedmy behavior, but the fact is that I sleep substantial-
ly better now compared to a month ago”. Some comments showed dis-
satisfaction with the treatment method, example quote: “My
depression depends on Parkinson, and I believe it can only be alleviated
by medications”. Other comments showed dissatisfaction with the
internet-based parts of treatment, example quote: “To hard to get in
contact. [I needed] more practical help and demonstration of the com-
puter system”. In summary, the participants' views of the treatment
weremixed, but it is clear that someparticipantswished formore active
input from the therapist.
4. Discussion
This study investigated the feasibility and effect of ICBT for depression
and anxiety in PD. The ICBT tested in the study was based on behavioral
activation for depression and optional symptom speciﬁc modules were
matched to each participant's needs. The results suggest that this form
of ICBT can be effective in the treatment of depressive symptoms in PD.
ICBT was associated with a signiﬁcant drop in HADS with a medium to
large within group effect, especially in the depressive symptoms sub-
scale HADS-D. No signiﬁcant effects were seen on anxiety symptoms
measured with the sub-scale HADS-A, or the secondary outcomes of in-
somnia, PD related health and quality of life, depressive symptoms mea-
sured with MADRS-S, or non-motor symptoms. The treatment might be
a cost effective treatment alternative since the therapist spent less than
15 min per participant and week, which is less than seen in previous
face-to-face or telephone-CBT (Dobkin et al., 2011a; Dobkin et al., 2011b).
Many participants were quite inactive in working with the home-
work assignments with an average of just three completed assignments
per person. The average number of messages sent to the therapist was
just above eight and the treatment evaluation form suggested that few
participants contacted the therapist every time they encountered a
problem. Three out of nine participants decided to end treatmentprematurely. This rate of drop-out was not seen in the studies of face-
to-face- or telephone-CBT done by Dobkin and colleagues (Dobkin
et al., 2011a; Dobkin et al., 2011b). Besides the different ways of admin-
istering treatment, the studies by Dobkin and colleagues also included
active caregiver support. Parkinson severity, deﬁned as mean UPDRS-
score, in this sample was similar to what was seen in the randomized
trial by Dobkin and colleagues (Dobkin et al., 2011a). The caregivers' en-
gagement in treatment was a signiﬁcant predictor of response to CBT
(Dobkin et al., 2012). In the current study, high initial problem severity
could also be a partial explanation to the rather inactive participants. PD
severity in this sample was similar to the PD severity seen in the ran-
domized trial by Dobkin and colleagues. On the other hand the levels
of non-motor symptoms, measured with NMSQuest, were in the range
of severe PD (Chaudhuri et al., 2006). Though participants on average
found the text mostly interesting and relevant, they were less satisﬁed
with treatment than participants in a comparable ICBT-treatment for
depression who in a large (n = 1203) effectiveness study (Hedman
et al., 2014), had amean sum score of 24.51 (4.75). This is a signiﬁcantly
higher degree of self-reported treatment satisfaction than in the present
study (t(1207)= 2.49; p b .05). Written comments, interview data and
the reasons for drop out suggest that some participants thought the
internet platform was hard to use and would have gained from either
a simpler system or more practical help with the current internet plat-
form. Many phone calls with participants were used for technical
counseling and these could perhaps be preventable with a more sim-
plistic technical solution. This is also supported by the participants'
comments and the reasons the three participants out of nine gave for ac-
tively leaving treatment. The involvement of a caregiver could be anoth-
er way to increase engagement in treatment and prevent inactivity and
drop out in future studies. A more active therapist may be a way to
counter that the participants were inactive in contacting the therapist
when they had a problem or a question.
Strengths of this study include the novelty of using an internet based
treatment on PD patients which is an often neglected group when it
comes to psychological treatments, the large number of questionnaire
and interview data measuring the participant's interaction and satisfac-
tion with treatment, and the signiﬁcant effect on themain outcome. In-
ternet based treatments have earlier rarely been used with patient
groupswith a high degree of functional impairment. The preliminary re-
sults indicating comparably low degrees of participant satisfaction and
involvement could be used as a warning not to assume that the adapta-
tions made in this treatment program were sufﬁcient.
This study also displays limitations. First, since this was a pilot study
without a control condition, any detected effect could be caused by non-
speciﬁc treatment factors such as time and the attention of a therapist.
Thus, the ﬁndings in this feasibility study need to be replicated in a ran-
domized controlled trial. Second, the small sample sizemakes the study
underpowered, leading to difﬁculty detecting treatment effects. Howev-
er, despite low statistical power there were signiﬁcant treatment effects
on the primary outcome measure. Third, there was no signiﬁcant drop
in depressive symptoms measured with MADRS-S similar to the drop
in HADS-D. However, HADS-D is more adapted to measure depression
in somatic patients than MADRS-S because of HADS-D's exclusion of
items affected by the physical illness of the patient (Zigmond and
Snaith, 1983). Fourth, only one psychologist (MK) treated the partici-
pants leading to difﬁculties generalizing the results to other therapists.
However, the therapeutic role of the psychologist was limited since
the treatment was delivered as guided self-help via the internet. Fifth,
the participants were recruited by a single neurologist (PS) and may
not be generalizable to the whole population of people with depression
and anxiety in PD. The high degree of non-motor symptomsmay for ex-
ample be an indication that the participants were unusually symptom-
atic in this sample. Finally, since assessors were not blinded to time
point, there could be a bias towards describing improvements in the
participants. However, the primary outcome measure and most other
measures were self-administered by the participant.
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pression and anxiety in PD include the need to adapt the treatment pro-
tocol to the patient group even further. The qualitative evaluation
regarding adherence anddrop out implies that the technological aspects
of treatment easily can become a hurdle for this patient group. The in-
ternet platform needs to be simple enough for the participants to use,
and the interaction between participants and therapist needs to be ac-
tive to ensure participant involvement in treatment. Additionally, the
engagement of a caregiver could motivate the participant to work
with the treatment assignments.
5. Conclusions
ICBT for depression and anxiety in PD could be a time saving and ac-
cessible alternative. The results are encouraging in that ICBT had effect
on depressive symptoms, however further adaptations of the ICBT pro-
gram, the type of therapeutic support, and technical platform could
probably improve the participants' involvement in treatment and satis-
faction. More feasibility trials of ICBT in different forms, as well as larger
randomized-controlled trials, with long term follow-up data, are war-
ranted to evaluate the short- and long-term efﬁcacy of ICBT for this
group of patients.
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